New combo therapy aims to speed up knee surgery recovery
NCT ID NCT07273032
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study tests whether a Chinese herbal formula (Henggu Bone Injury Healing Agent) and a lower-limb rehabilitation system, alone or together, can improve recovery after arthroscopic meniscus repair. 120 adults aged 20-65 will be split into four groups and followed for 6 months. The goal is to see if these interventions reduce pain and improve knee function better than standard care.
What this could mean
Our plain-language read of the trial. This is informational only, not medical advice or a prediction.
- Active substance
- Henggu Bone Injury Healing Agent (herbal formula)
- What this could lead to
- If successful, this could provide a better recovery plan after meniscus surgery, reducing pain and improving knee function.
- What could go wrong
- This is a small, early-phase trial with only 120 participants. The herbal formula and rehab system may not show significant benefit over standard care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Study facts
What this study's own registry entry says, in plain language.
- Phase
-
Phase 4
Runs after approval, following long-term safety and how well the treatment works in everyday use.
- Participants
-
About 120 people
The number the study aims to enrol. It can still change while the study runs.
- Expected to start
-
Dec 2025
An estimate. Start dates often move.
- Expected to finish
-
Dec 2026
An estimate. End dates often move.
- Lead sponsor
-
A government agency
The lead sponsor is a government body.
Who can take part
This study's own entry requirements. Only the study team can say for certain whether you qualify.
- Ages
-
20 to 65 years
- Sex
-
Anyone
- Healthy volunteers
-
Not accepted
This study is not open to healthy volunteers. The entry requirements below say who it is open to.
Show the full entry requirements Hide the full entry requirements
Copied word for word from the study's registry entry, so the wording is the study team's rather than ours.
Inclusion Criteria: (1) Patients with meniscus injury were conscious and aware of the content of this study. (2) Good compliance and cooperation with relevant drug treatments; (3) Possess good language communication skills. Exclusion Criteria: Patients with severe obesity; (2) People with cognitive dysfunction (such as Alzheimer's disease); (3) Those with severe heart, liver or kidney insufficiency.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for Meniscus injury are added.
Genom att skicka in godkänner du våra Användarvillkor
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
How to take part
Only the study team decides who joins. These are the ways to reach them.
-
The official record
The full official record for this study. This one lists no contact details, but it is the first place any would appear.
-
A doctor treating you
A doctor who knows your case can contact a study site on your behalf, and can tell you whether this study is worth pursuing at all.
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can saving the meniscus save knees from osteoarthritis?
- Knee repair boost? microfracture may help meniscus healing
- Tape your way to less knee pain? new study tests kinesiotaping for meniscus tears
- Study reveals hidden link between muscle weakness and fear after meniscus injury
- New knee surgery could help Bow-Legged patients with meniscus tears